25-04-2024
|
|
|
Zydus Lifesciences Limited has informed the Exchange regarding 'Demand Order-In-Original for the financial year 2018-19 on the issue pertaining to Excess Claim of Input Tax Credit received from Office of the Deputy Commissioner, Ghaziabad-I, Uttar Pradesh'. |
|
|
|
24-04-2024
|
|
|
Zydus Lifesciences Limited has informed the Exchange regarding 'Inspection held at the Injectable Manufacturing site situated at Jarod, near Vadodara'. |
|
|
|
23-04-2024
|
|
|
Zydus Lifesciences Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
23-04-2024
|
|
|
ZYDUS LIFESCIENCES LIMITED has informed the Exchange about Loss of share certificates |
|
|
|
23-04-2024
|
|
|
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 23, 2024, titled "New Drug Application of Zydus innovative drug Desidustat tablets by China Medical System Holdings Limited accepted in China". |
|
|
|
22-04-2024
|
|
|
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 22, 2024, titled "Zydus launches Mirabegron Extended-Release Tablets in the US". |
|
|
|
20-04-2024
|
|
|
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 20, 2024, titled "Sentynl Therapeutics receives marketing authorization for NULIBRY?? (fosdenopterin) from the UK MHRA for treatment of MoCD Type A". |
|
|
|
12-04-2024
|
|
|
Zydus Lifesciences Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
12-04-2024
|
|
|
ZYDUS LIFESCIENCES LIMITED has informed the Exchange about Loss of share certificates |
|
|
|
10-04-2024
|
|
|
Zydus Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
|
|